Seroatlas · Human Serome Atlas

PTAFR

Platelet-activating factor receptor

Also known as: PTAFR_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P25105
Gene
PTAFR
Ensembl
ENSG00000169403
Chromosome
1
Canonical length
342 aa
Protein class
FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm,Vesicles,Plasma membrane,Primary cilium

OverviewNCBI Gene

This gene encodes a seven-transmembrane G-protein-coupled receptor for platelet-activating factor (PAF) that localizes to lipid rafts and/or caveolae in the cell membrane. PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is a phospholipid that plays a significant role in oncogenic transformation, tumor growth, angiogenesis, metastasis, and pro-inflammatory processes. Binding of PAF to the PAF-receptor (PAFR) stimulates numerous signal transduction pathways including phospholipase C, D, A2, mitogen-activated protein kinases (MAPKs), and the phosphatidylinositol-calcium second messenger system. Following PAFR activation, cells become rapidly desensitized and this refractory state is dependent on PAFR phosphorylation, internalization, and down-regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Canonical amino-acid sequenceUniProt

342 residues, UniProt reviewed canonical sequence.

>P25105|PTAFR
     1  MEPHDSSHMD SEFRYTLFPI VYSIIFVLGV IANGYVLWVF ARLYPCKKFN EIKIFMVNLT
    61  MADMLFLITL PLWIVYYQNQ GNWILPKFLC NVAGCLFFIN TYCSVAFLGV ITYNRFQAVT
   121  RPIKTAQANT RKRGISLSLV IWVAIVGAAS YFLILDSTNT VPDSAGSGNV TRCFEHYEKG
   181  SVPVLIIHIF IVFSFFLVFL IILFCNLVII RTLLMQPVQQ QRNAEVKRRA LWMVCTVLAV
   241  FIICFVPHHV VQLPWTLAEL GFQDSKFHQA INDAHQVTLC LLSTNCVLDP VIYCFLTKKF
   301  RKHLTEKFYS MRSSRKCSRA TTDTVTEVVV PFNQIPGNSL KN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PTAFR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
7
Mean surface accessibility (rSASA)
0.3
Highest tissue expression
39 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 39 nTPM
  • appendix: 29 nTPM
  • tonsil: 17 nTPM
  • lung: 17 nTPM
  • spleen: 14 nTPM
  • urinary bladder: 13 nTPM

Single-cell type

  • neutrophils: 466 nCPM
  • kupffer cells: 147 nCPM
  • monocytes: 145 nCPM
  • neutrophil progenitors: 117 nCPM
  • microglia: 115 nCPM
  • hofbauer cells: 114 nCPM

Immune cell

  • eosinophil: 909 nTPM
  • neutrophil: 750 nTPM
  • classical monocyte: 257 nTPM
  • myeloid DC: 116 nTPM
  • total PBMC: 112 nTPM
  • intermediate monocyte: 78 nTPM

Brain region

  • white matter: 23 nTPM
  • medulla oblongata: 17 nTPM
  • spinal cord: 16 nTPM
  • pons: 14 nTPM
  • thalamus: 14 nTPM
  • midbrain: 13 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.85
gnomAD pLI
0.24
gnomAD missense Z
1.45
DepMap mean gene effect
0.03
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of PTAFR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PTAFR as an antibody target. Whether an autoantibody or antibody against PTAFR could matter depends on whether native PTAFR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PTAFR is annotated at the cell surface, where native PTAFR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label PTAFR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PTAFR. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...